Title
Author
DOI
Article Type
Special Issue
Volume
Issue
1Department of Pediatric Dentistry, Tufts University School of Dental Medicine, 1 Kneeland Street, Boston, MA 02111, USA. Nutricia USA, 6111 Broker sound Parkway NW, Boca Raton, FL 33487, USA
2Department of Pediatric Dentistry, Tufts University School of Dental Medicine, 1 Kneeland Street, Boston, MA 02111, USA
DOI: 10.17796/jcpd.25.3.gx4131w514x45138 Vol.25,Issue 3,July 2001 pp.249-253
Published: 01 July 2001
Attention Deficit/Hyperactivity Disorder (AD/HD) is characterized by a cluster of age-inappropriate behavioral abnormalities comprising inattentivity, hyperactivity and impulsivity. The definition is con-troverisal and without an accurate diagnosis. Therefore, it seems prudent that a multidisciplinary treat-ment protocol should begin with non-drug psychological and behavioral strategies plus nutritional intervention.
Guru Ramanathan,George E. White. Attention-deficit/hyperactive disorder: making a case for multidisciplinary management. Journal of Clinical Pediatric Dentistry. 2001. 25(3);249-253.
1. NIH news release located at http://www.nih.gov/news/pr/nov98/od-18.htm
Diagnosis and Treatment of Attention Deficit Hyperactivity Dis-order. NIH Consens Statement online. 16: 16-18; 1998.
2. American Psychiatric Association. Diagnostic and Statistic Man-ual of Mental Disorders, Fourth Edition. Washington, DC: Amer-ican Psychiatric Association; 1994
3. Thapar A, Holmes J, Poulton K, Harrington R. Genetic basis of attention deficit and hyperactivity, British Journal of Psychiatry 174: 105-111, 1999.
4. Robison LM, Sclar DA, Skaer TL, Galin RS. National trends in the prevalence of attention deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995. Clin Pediatr 38: 209-217, 1999.
5. Elia J, Ambrosini PJ and Rapoport JL. Treatment of attention deficit hyperactivity disorder, N Engl J Med 340: 780-788, 1999.
6. Biederman J. Attention-deficit/hyperactivity disorder: A life-span perspective. J Clin Psychiatry 59 [suppl 7]: 4-16, 1998.
7. Unsaturated Fatty acids: nutritional and physiological signifi-cance, report of the British nutritional foundation’s task force. ed. Chapman and Hall, London 1992.
8. Richardson AJ and Puri BK. The potential role of fatty acids in attention-deficit/hyperactivity disorder. Prostaglandins Leukotr Essent Fatty Acids 63: 79-87, 2000.
9. Colquhon I, Bunday S. A lack of essential fatty acid as a possible cause of hyperactivity in children. Medical Hypothesis 7: 173, 1981.
10. Mitchell E, Lewis S, Cutler DR. Essential fatty acids and malad-justed behavior in children. Prostaglandins Leukotrienes and Essential Fatty Acids 12: 281-287, 1983.
11. Mitchell E, Aman M, Turbott S, Manku M. Clinical characteris-tics and serum essential fatty acid levels in hyperactive children. Clin Pediatr 26(8): 406-411, 1987.
12. Aman MG, Mitchell EA, Turbott SH. The effects of essential fatty acid supplementation by efamol in hyperactive children. J Abnorm Child Psychol 15: 75-90, 1987.
13. Arnold LE, Kleykamp D, Votolato NA, Taylor WA, Kontras SB and Tobin K. Gammalinolenic acid for attention deficit hyperac-tivity disorder: Placebo controlled comparison to D-ampheta-mine. Biol Psychiatry 25: 222-228, 1989.
14. Arnold LE, Kleykamp D, Votolato NA, Gibson RA and Hor-rocks L. Potential link between dietary intake of fatty acids and behavior: Pilot exploration of serum lipids in attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 4(3): 171- 182, 1994.
15. Stevens LJ, Zentall SS, Deck JL, Abate ML, Watkins BA, Lipp SR, Burgess, JR. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. American Journal of Clinical Nutrition 62: 761-768, 1995.
16. Stevens LJ, Zentall SS,Abate ML, Kuczek T, Burgess JR. Omega-3 fatty acids in boys with behavior, learning and health problems. Physiology & Behavior 59: 915-920, 1996.
17. Hamazaki T, Sawazaki, Itomura, Asaoka E, Nagao Y, Nishimura N, Yazawa K, Kuwamori T and Kobayashi M. The effect of docosahexaenoic acid on aggression in young adults. J Clin. Invest 97(4): 1129-1134, 1996.
Top